Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Clinical Benefit and Safety of Reduced Elective Dose in Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma: The UPGRADE-RT Multicenter Randomized Controlled Trial

DOI Full Paper Access

13

Citations

23

References

2025

Year

Sven van den Bosch, Patricia Doornaert, Frank Hoebers, Bas Kreike, Marije R. Vergeer, Ellen M. Zwijnenburg, Maurice C. Cox, Gerjon Hannink, Tim Dijkema, Johannes H.A.M. Kaanders

Journal of Clinical Oncology

Abstract

This is the second randomized controlled trial demonstrating that reduced elective dose is safe in definitive RT for HNC.

References

	Year	Citations

Page 1